1. Home
  2. MTRN vs XNCR Comparison

MTRN vs XNCR Comparison

Compare MTRN & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTRN
  • XNCR
  • Stock Information
  • Founded
  • MTRN 1931
  • XNCR 1997
  • Country
  • MTRN United States
  • XNCR United States
  • Employees
  • MTRN N/A
  • XNCR N/A
  • Industry
  • MTRN Industrial Specialties
  • XNCR Biotechnology: Pharmaceutical Preparations
  • Sector
  • MTRN Industrials
  • XNCR Health Care
  • Exchange
  • MTRN Nasdaq
  • XNCR Nasdaq
  • Market Cap
  • MTRN 2.0B
  • XNCR 1.7B
  • IPO Year
  • MTRN N/A
  • XNCR 2013
  • Fundamental
  • Price
  • MTRN $100.92
  • XNCR $19.24
  • Analyst Decision
  • MTRN Strong Buy
  • XNCR Strong Buy
  • Analyst Count
  • MTRN 2
  • XNCR 9
  • Target Price
  • MTRN $143.50
  • XNCR $36.33
  • AVG Volume (30 Days)
  • MTRN 114.0K
  • XNCR 766.2K
  • Earning Date
  • MTRN 02-13-2025
  • XNCR 02-25-2025
  • Dividend Yield
  • MTRN 0.53%
  • XNCR N/A
  • EPS Growth
  • MTRN N/A
  • XNCR N/A
  • EPS
  • MTRN 3.54
  • XNCR N/A
  • Revenue
  • MTRN $1,668,911,000.00
  • XNCR $85,164,000.00
  • Revenue This Year
  • MTRN $3.05
  • XNCR N/A
  • Revenue Next Year
  • MTRN $6.29
  • XNCR $80.86
  • P/E Ratio
  • MTRN $28.55
  • XNCR N/A
  • Revenue Growth
  • MTRN N/A
  • XNCR N/A
  • 52 Week Low
  • MTRN $93.20
  • XNCR $15.31
  • 52 Week High
  • MTRN $145.08
  • XNCR $27.24
  • Technical
  • Relative Strength Index (RSI)
  • MTRN 48.12
  • XNCR 29.84
  • Support Level
  • MTRN $93.20
  • XNCR $19.05
  • Resistance Level
  • MTRN $98.42
  • XNCR $24.66
  • Average True Range (ATR)
  • MTRN 2.69
  • XNCR 1.10
  • MACD
  • MTRN 0.77
  • XNCR -0.49
  • Stochastic Oscillator
  • MTRN 91.36
  • XNCR 3.26

About MTRN Materion Corporation

Materion Corp is a producer of engineered materials based in the United States. The company produces materials used in electrical, electronic, thermal, and structural applications. The company operates in four reportable segments: Performance Materials, Electronic Materials, Precision Optics, and Other. The majority of revenue is derived from Electronic Materials which produces chemicals, microelectronics packaging, precious metal, non-precious metal, and specialty metal products, including vapor deposition targets, frame lid assemblies, clad and precious metal pre-forms, high temperature braze materials, and ultra-pure wire.

About XNCR Xencor Inc.

Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases such with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045, XmAb662 among others. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.

Share on Social Networks: